← 產業報告目錄

AI in Oncology Market Size, Share & Trends Analysis Distribution by type of cancer (Solid Malignancies, Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor), Type of end users (Hospitals, Pharmaceutical Companies, Research Institutes) and Segment Forecasts, 2024-2031

出版商 InsightAce Analytic產業別 ICT & Media出版日期 2026-02-01頁數 180報告編號 INSIGHTACE-6a6361f056

授權報價

Single User PDF$4,500 USD
Global Site License PDF$9,500 USD
洽詢購買 申請 Sample

報告摘要

A CAGR of 18.8% is forecasted for the global AI in Oncology Market over the assessment period of 2024 through 2031. The AI in Oncology sector involves The field of oncology is experiencing rapid advancements with the integration of artificial intelligence (AI), which employs advanced algorithms and machine learning techniques to enhance cancer diagn. This domain has witnessed notable transformation owing to technological breakthroughs and shifting technology and communications dynamics. The market's upward path is supported by escalating healthcare spending, technological evolution, and the escalating focus on personalized and precision-based approaches in technology and communications. From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities. From a regional perspective, mature markets in North America and Europe continue to hold notable shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and escalating investment in the sector. The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion. This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
目錄 Table of Contents
Chapter 1. Methodology and Scope 1.1. Research Methodology 1.2. Research Scope & Assumptions Chapter 2. Executive Summary Chapter 3. Global AI in Oncology Market Snapshot Chapter 4. Global AI in Oncology Market Variables, Trends & Scope 4.1. Market Segmentation & Scope 4.2. Drivers 4.3. Challenges 4.4. Trends 4.5. Investment and Funding Analysis 4.6. Industry Analysis – Porter's Five Forces Analysis 4.7. Competitive Landscape & Market Share Analysis 4.8. Impact of Covid-19 Analysis Chapter 5. Market Segmentation 1: by Type of Cancer Estimates & Trend Analysis 5.1. by Type of Cancer & Market Share, 2019 & 2031 5.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Type of Cancer: 5.2.1. Solid Malignancies 5.2.2. Breast Cancer 5.2.3. Lung Cancer 5.2.4. Prostate Cancer 5.2.5. Colorectal Cancer 5.2.6. Brain Tumor 5.2.7. Others Chapter 6. Market Segmentation 2: by End-users Estimates & Trend Analysis 6.1. by End-users & Market Share, 2019 & 2031 6.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following by End-users: 6.2.1. Hospitals 6.2.2. Pharmaceutical Companies 6.2.3. Research Institutes 6.2.4. Others Chapter 7. AI in Oncology Market Segmentation 3: Regional Estimates & Trend Analysis 7.1. North America 7.1.1. North America AI in Oncology Market Revenue (US$ Million) Estimates and Forecasts by Type of Cancer, 2024-2031 7.1.2. North America AI in Oncology Market Revenue (US$ Million) Estimates and Forecasts by End-users, 2024-2031 7.1.3. North America AI in Oncology Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031 7.2. Europe 7.2.1. Europe AI in Oncology Market Revenue (US$ Million) Estimates and Forecasts by Type of Cancer, 2024-2031 7.2.2. Europe AI in Oncology Market Revenue (US$ Million) Estimates and Forecasts by End-users, 2024-2031 7.2.3. Europe AI in Oncology Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031 7.3. Asia Pacific 7.3.1. Asia Pacific AI in Oncology Market Revenue (US$ Million) Estimates and Forecasts by Type of Cancer, 2024-2031 7.3.2. Asia Pacific AI in Oncology Market Revenue (US$ Million) Estimates and Forecasts by End-users, 2024-2031 7.3.3. Asia Pacific AI in Oncology Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031 7.4. Latin America 7.4.1. Latin America AI in Oncology Market Revenue (US$ Million) Estimates and Forecasts by Type of Cancer, 2024-2031 7.4.2. Latin America AI in Oncology Market Revenue (US$ Million) Estimates and Forecasts by End-users, 2024-2031 7.4.3. Latin America AI in Oncology Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031 7.5. Middle East & Africa 7.5.1. Middle East & Africa AI in Oncology Market Revenue (US$ Million) Estimates and Forecasts by Type of Cancer, 2024-2031 7.5.2. Middle East & Africa AI in Oncology Market Revenue (US$ Million) Estimates and Forecasts by End-users, 2024-2031 7.5.3. Middle East & Africa AI in Oncology Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031 Chapter 8. Competitive Landscape 8.1. Major Mergers and Acquisitions/Strategic Alliances 8.2. Company Profiles 8.2.1. Berg 8.2.2. CancerCenter.AI 8.2.3. Concert AI 8.2.4. GE Healthcare 8.2.5. IBM Watson Health 8.2.6. iCAD 8.2.7. JLK Inspection 8.2.8. Median Technologies 8.2.9. Path AI 8.2.10. Roche Diagnostic 8.2.11. Other Prominent Players

量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們